Minireviews Open Access
Copyright ©The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Dermatol. Aug 2, 2015; 4(3): 129-134
Published online Aug 2, 2015. doi: 10.5314/wjd.v4.i3.129
X linked recessive ichthyosis: Current concepts
Jaime Toral-López, Departamento de Genética Médica, Centro Médico Ecatepec, Instituto de Seguridad Social del Estado de México y Municipios, Ecatepec, Estado de México CP 55000, México
Luz María González-Huerta, Sergio A Cuevas-Covarrubias, Departamento de Genética Médica, Hospital General de México/Facultad de Medicina, Universidad Nacional Autónoma de México, Ciudad de México CP 06726, México
Author contributions: Toral-López J, González-Huerta LM and Cuevas-Covarrubias SA performed the review.
Conflict-of-interest statement: The authors declare no conflict of interest.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See:
Correspondence to: Dr. Sergio A Cuevas-Covarrubias, Departamento de Genética Médica, Hospital General de México/Facultad de Medicina, Universidad Nacional Autónoma de México, Dr. Balmis 148 Col. Doctores, Ciudad de México CP 06726, México.
Telephone: +52-55-27892000 Fax: +52-55-53412821
Received: November 22, 2014
Peer-review started: November 22, 2014
First decision: January 8, 2015
Revised: May 8, 2015
Accepted: May 27, 2015
Article in press: May 28, 2015
Published online: August 2, 2015


In the present review, we describe the most important aspects of the X-linked ichthyosis (XLI) and make a compilation of the some historic details of the disease. The aim of the present study is an update of the XLI. Historical, clinical, epidemiological, and molecular aspects are described through the text. Recessive XLI is a relatively common genodermatosis affecting different ethnic groups. With a high spectrum of the clinical manifestations due to environmental factors, the disease has a genetic heterogeneity that goes from a point mutation to a large deletion involving several genes to produce a contiguous gene syndrome. Most XLI patients harbor complete STS gene deletion and flanked sequences; seven intragenic deletions and 14 point mutations with a complete loss of the steroid sulfatase activity have been reported worldwide. In this study, we review current knowledge about the disease.

Key Words: STS gene, X-linked ichthyosis, Steroid sulfatase, Gene deletion, Contiguous gene syndrome, Genodermatosis

Core tip: In the present study we describe the current knowledge of historical, clinical, epidemiological, physiopathological and molecular data in the X-linked ichthyosis (XLI). We consider that this review is important due to XLI is one of the most frequent genodermatosis that affects similarly to different ethnic groups worldwide.


The term ichthyosis has been used for over 2000 years and comes from the Greek root “ichthys” meaning fish. In the nineteenth century, the Indians and Chinese referred to the disease as “a condition of snakeskin or fish scales” and at the time of the Arab physician Avicenna as “nigra albarras”. The first description of ichthyosis documented in the medical literature was in the work “On cutaneous diseases” by Wilan[1] in 1908. Cockayne[2] in 1933, was the first to describe cases of ichthyosis in males and used the genetic classification. In 1965, Wells et al[3] could distinguish the X-linked ichthyosis (XLI) from the dominant ichthyosis vulgaris. They suggested that the onset of dominant form was present after three months with a less body affection. In 1978, Koppe et al[4] and Webster et al[5] identified the absence of the steroid sulfatase (STS) enzyme in fibroblasts of patients with XLI.


XLI (OMIM 308100) is a genodermatosis caused for STS deficiency[4,5]; it is characterized by abnormal desquamation and hiperqueratosis in the skin[6], and is due excessive amounts of cholesterol sulfate in the epidermis[7]. XLI has a frequency of one to two in 6000 men[8]. With respect to the genetics of X-linked recessive disorders, these diseases are generally restricted to males, these ones transmit the affected gene only to females (obligated carriers). Carriers of the X-linked gene defect have a risk of 50% to have affected males or carriers females.

The STS protein has 583 amino acids with a molecular weight of 62 kDa. The first 22 amino acids correspond to the leader peptide, which is cleaved post-translationally to give rise to the mature enzyme[9]. STS protein has 4 glycosylation sites[10]. The STS enzyme is attached to the rough endoplasmic reticulum and hydrolyzes the sulfate groups of the sulfated 3 β-hydroxysteroids such as dehydroepiandrosterone sulfate (DHEAS), cholesterol sulfate, pregnenolone sulfate and androstenediol 3 sulfate[11-13], metabolites that serve as precursors for estrogens, androgens, and cholesterol. STS is expressed on placenta, breast, immune system, brain, liver, reproductive tract and blood cells[10]. In placenta, STS deconjugates DHEAS, a previous step for the oestrogen synthesis during pregnancy. STS enzyme is upregulated by tumor necrosis factor α and interleukin (IL)-6, while IL-1β and interferon-γ downregulate it by inhibiting nuclear factor-kappa-B and activiting glucocorticoid receptor. Retinoids and 1,25(HO)2-vitamin D3 induce its activity and expression[14,15].

The STS gene is located in the Xp22.3 region[16,17], and has 10 exons, 2 untranslated regions (at the 5’ of 206 bp and at the 3’ of 668 bp), and one open reading frame of 1752 bp[18-20]. The Xp22.3 region escapes to X-inactivation[16,21]. More than 90% of XLI patients present a complete STS gene deletion and flanked sequences, the remainders have showed 7 intragenic deletions[22-28] whereas 14 point mutations with a complete loss of the STS activity[29-38] have been reported. Contiguous gene deletions around the STS leading to a more complex phenotype associated with short stature, chondrodysplasia punctata, Kallman syndrome and ocular albinism[39].

One explanation for the deletion of the STS gene and flanking sequences on the short arm of the X chromosome is the presence of families of repeated sequences in low copy number (G1.3 and CRI-S232) on both sides of the STS gene[40-43]. In women, the presence of these sequences could produce an unequal homologous recombination; however, another proposed mechanism is a mismatch by sliding DNA chains as shown the paternal origin of the affected X chromosome[22,44-46].


Mothers of affected fetus con XLI may present delayed or prolonged labor due the absence of STS enzyme in the placenta[47]. Onset of symptoms of the XLI is in the first months of life by the presence of polygonal, loosely adherent translucent scales with a generalized distribution[48]. The scales predominantly are in anterior abdomen, preauricular area, neck, axillae and extension zones of the limbs[3,49-52]. The scalp is affected in childhood and this affection disappears in the adulthood. Generally, scales spare palms, soles, popliteal and antecubital fossae and the mid-face[52-54]. Clinical manifestations are worse in cold/dry weather. XLI patients have low sweat production due to a decrease numbers of sweat gland[55]. Filaggrin mutations may be associated with ichthyosis vulgar, xerosis and atopic dermatitis exacerbating the XLI phenotype[56,57]. Extracutaneous manifestations, such as ocular defects, have been observed in 10%-15% of patients and up to 25% of carrier mothers[58]. Diffuse deposits in the corneal stromal and descemet membrane[59], may appear at any time of life, they predominate in the 2nd and 3rd decade without affect visual acuity[60,61]. Back embryotoxon, deuteranopia, corneal erosion[62,63] has also been observed. Cryptorchidism is observed in 20% of cases[64], with a cancer high risk of testicular germ cells[65]. Neurological alterations have been observed in patients with XLI, such as epilepsy, electroencephalogram abnormalities, mental retardation, hyposmia[66], attention deficit hiperactivity disorder, autism and speech deficit; these manifestations have been attributed to altered sterol metabolism in the central nervous system[67,68] frequently associated with contiguous gene deletion. Others anomalies less frequent are seizures, psychological disorders[69,70], pyloric hypertrophy[71,72], abdominal wall defects, leukemia, nodular heterotopia periventricular[73,74] and steroid-resistant nephrotic syndrome[75].


Cholesterol sulfotransferase (SULT2B1b) generates cholesterol sulfate (CS) in lower nucleated cell layers (stratum basal) of the epidermis, increasing the concentration of CS from 1% to 5% on the stratum granulosum[52]. STS enzyme decreases CS to 1% in the stratum corneum (outer epidermis)[52,76,77]. The increase of CS induces the expression of the skin barrier protein filaggrin and plays a role in the differentiation of normal keratinocyte[78,79]. Rupture of CS cycle by STS defect produces an increase of CS from 1% to 10%-12% in the stratum corneum of the epidermis[7]; this results in: (1) a decrease barrier function with a failure of the normal liquid-crystalline transition phase of intercellular lipids; and (2) an abnormal corneocyte retention stimuling the hyperplasia epidermal-inflamation and a thickened stratum corneum. The increase of CS is in relation with the decrease of the activity serine protease and the increase of Ca2+, producing corneodesmosomal retention[6,52,80]. Besides, the dark color of the scales could be explained by the presence of large amounts of melanosomes in the corneal cells[81].


Prenatal diagnosis can be carried out through the study of triple marker in second trimester of pregnancy which detects low or absent serum levels of estriol. The suspect of a fetus with XLI is associated with a decrease level of estrogen and the presence of unhydrolyzed steroid sulfates in maternal urine[82-84]; a history of prolonged labor and delivery increases this possibility. The analysis of the STS gene through southern blot, in situ hybridization, polymerase chain reaction can be made ​​on chorionic villi or amniotic liquid when the familial genetic defect is known[85]. Determination of steroid sulfatase activity and polymerase chain reaction, fluorescence in situ hibridation and DNA of the STS gene analyses allow to discard XLI[31,32,34,41,86]. New techniques as MLPA, DNA microarrays, total exome sequencing is helping to prove the complete deletion, partial deletions or point mutations in the STS gene. Histopatological study is not useful for the diagnosis of XLI, however it may be useful in the differential diagnosis of XLI with other specific histopathology entities[6].


XLI differential diagnosis mainly is with ichthyosis vulgaris and others ichthyosis like lamellar ichthyosis[50,54,87]. Ichthyosis vulgaris (IV) is characterized by symmetric light gay scaling, generally after 3 mo of age; flexion zones are affected and inheritance pattern is dominant autosomal, nevertheless in some cases it can be acquired. Biopsy studies of skin appear similar in both cases. In sporadic cases is most difficult to stablish the correct diagnosis, because it is not present a specific inheritance pattern. In familiar cases, genealogy is an important tool to correctly identify XLI from IV. The determination of STS activity is the golden standard in the differential diagnosis of both diseases but molecular studies of STS or FLG genes are also useful to perform the correct diagnosis.


XLI has not definitive treatment, but fortunately, except for the aesthetic appearance, rarely affects normal life function. XLI mainly affects the skin that is exacerbated in winter, but improves in summer. Lubricants, humectants and keratolytic agents are indicated when there is excessive large scale or keratinization[88]. There are few studies on the treatment of XLI, one study used tazarotene 0.05% and glycolic acid 70% in a patient with a large deletion of the STS gene, with good response, but with a remission to the 8 and 2 mo, respectively[89], another study used calcipotriol in 8 cases with XLI and 11 patients with congenital ichthyosis and showed reduction of scaling and roughness[90]. On a heterogeneous study[91], liarozole vs oral acitretin were compared with no significant differences[92]. Generally, XLI treatment is based upon studies in other groups of congenital or heterogeneous ichthyoses[93-95]. In neonates and infants, keratolytics should be handled with caution because they are absorbed due to the immature skin barrier causing toxicity. Any treatment regimen works for everyone, and the best therapy for each patient may be the result of months or years of painstaking effort on both the physician’s and the patient’s behalf. It is important to keep in mind the cost of the topical treatments[88]. Multidisciplinary management with various specialists such as dermatologists, geneticists, ophthalmologists, psychologists, gynecologists should be considered.


P- Reviewer: Cascella R, González-López MA, Suriyaphol G, Torres-álvarez MB S- Editor: Gong XM L- Editor: A E- Editor: Liu SQ

1.  Wilan R Ichthyosis. In: On cutaneous diseases. London: Barnard 1808; 197-212.  [PubMed]  [DOI]  [Cited in This Article: ]
2.  Cockayne EA Inherited abnormalities of the skin and its appendages. London: Oxford University Press 1933; .  [PubMed]  [DOI]  [Cited in This Article: ]
3.  Wells RS, Kerr CB. Genetic classification of ichthyosis. Arch Dermatol. 1965;92:1-6.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 96]  [Cited by in F6Publishing: 96]  [Article Influence: 4.6]  [Reference Citation Analysis (0)]
4.  Koppe G, Marinković-Ilsen A, Rijken Y, De Groot WP, Jöbsis AC. X-linked icthyosis. A sulphatase deficiency. Arch Dis Child. 1978;53:803-806.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 81]  [Cited by in F6Publishing: 86]  [Article Influence: 1.9]  [Reference Citation Analysis (0)]
5.  Webster D, France JT, Shapiro LJ, Weiss R. X-linked ichthyosis due to steroid-sulphatase deficiency. Lancet. 1978;1:70-72.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 201]  [Cited by in F6Publishing: 227]  [Article Influence: 5.0]  [Reference Citation Analysis (0)]
6.  Shwayder T. Disorders of keratinization: diagnosis and management. Am J Clin Dermatol. 2004;5:17-29.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 32]  [Cited by in F6Publishing: 36]  [Article Influence: 1.9]  [Reference Citation Analysis (0)]
7.  Williams ML, Elias PM. Stratum corneum lipids in disorders of cornification: increased cholesterol sulfate content of stratum corneum in recessive x-linked ichthyosis. J Clin Invest. 1981;68:1404-1410.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 163]  [Cited by in F6Publishing: 170]  [Article Influence: 4.0]  [Reference Citation Analysis (0)]
8.  Wells RS, Kerr CB. Clinical features of autosomal dominant and sex-linked ichthyosis in an English population. Br Med J. 1966;1:947-950.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 158]  [Cited by in F6Publishing: 165]  [Article Influence: 23.6]  [Reference Citation Analysis (0)]
9.  Vaccaro AM, Salvioli R, Muscillo M, Renola L. Purification and properties of arylsulfatase C from human placenta. Enzyme. 1987;37:115-126.  [PubMed]  [DOI]  [Cited in This Article: ]
10.  Reed MJ, Purohit A, Woo LW, Newman SP, Potter BV. Steroid sulfatase: molecular biology, regulation, and inhibition. Endocr Rev. 2005;26:171-202.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 381]  [Cited by in F6Publishing: 384]  [Article Influence: 21.3]  [Reference Citation Analysis (0)]
11.  French AP, Warren JC. Properties of steroid sulphatase and arylsulphatase activities of human placenta. Biochem J. 1967;105:233-241.  [PubMed]  [DOI]  [Cited in This Article: ]
12.  Hobkirk R. Steroid sulfotransferases and steroid sulfate sulfatases: characteristics and biological roles. Can J Biochem Cell Biol. 1985;63:1127-1144.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 154]  [Cited by in F6Publishing: 166]  [Article Influence: 4.4]  [Reference Citation Analysis (0)]
13.  Dibbelt L, Kuss E. Human placental sterylsulfatase. Interaction of the isolated enzyme with substrates, products, transition-state analogues, amino-acid modifiers and anion transport inhibitors. Biol Chem Hoppe Seyler. 1991;372:173-185.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 38]  [Cited by in F6Publishing: 37]  [Article Influence: 1.2]  [Reference Citation Analysis (0)]
14.  Hattori K, Yamaguchi N, Umezawa K, Tamura H. Interferon gamma induces steroid sulfatase expression in human keratinocytes. Biol Pharm Bull. 2012;35:1588-1593.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 4]  [Cited by in F6Publishing: 5]  [Article Influence: 0.5]  [Reference Citation Analysis (0)]
15.  Hughes PJ, Twist LE, Durham J, Choudhry MA, Drayson M, Chandraratna R, Michell RH, Kirk CJ, Brown G. Up-regulation of steroid sulphatase activity in HL60 promyelocytic cells by retinoids and 1alpha,25-dihydroxyvitamin D3. Biochem J. 2001;355:361-371.  [PubMed]  [DOI]  [Cited in This Article: ]
16.  Mohandas T, Shapiro LJ, Sparkes RS, Sparkes MC. Regional assignment of the steroid sulfatase-X-linked ichthyosis locus: implications for a noninactivated region on the short arm of human X chromosome. Proc Natl Acad Sci USA. 1979;76:5779-5783.  [PubMed]  [DOI]  [Cited in This Article: ]
17.  Müller CR, Wahlström J, Ropers HH. Further evidence for the assignment of the steroid sulfatase X-linked ichthyosis locus to the telomer of Xp. Hum Genet. 1981;58:446.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 12]  [Cited by in F6Publishing: 13]  [Article Influence: 0.3]  [Reference Citation Analysis (0)]
18.  Ballabio A, Parenti G, Carrozzo R, Sebastio G, Andria G, Buckle V, Fraser N, Craig I, Rocchi M, Romeo G. Isolation and characterization of a steroid sulfatase cDNA clone: genomic deletions in patients with X-chromosome-linked ichthyosis. Proc Natl Acad Sci USA. 1987;84:4519-4523.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 93]  [Cited by in F6Publishing: 109]  [Article Influence: 3.0]  [Reference Citation Analysis (0)]
19.  Yen PH, Allen E, Marsh B, Mohandas T, Wang N, Taggart RT, Shapiro LJ. Cloning and expression of steroid sulfatase cDNA and the frequent occurrence of deletions in STS deficiency: implications for X-Y interchange. Cell. 1987;49:443-454.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 190]  [Cited by in F6Publishing: 209]  [Article Influence: 5.8]  [Reference Citation Analysis (0)]
20.  Stein C, Hille A, Seidel J, Rijnbout S, Waheed A, Schmidt B, Geuze H, von Figura K. Cloning and expression of human steroid-sulfatase. Membrane topology, glycosylation, and subcellular distribution in BHK-21 cells. J Biol Chem. 1989;264:13865-13872.  [PubMed]  [DOI]  [Cited in This Article: ]
21.  Siegel DH, Sybert VP. Mosaicism in genetic skin disorders. Pediatr Dermatol. 2006;23:87-92.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 11]  [Cited by in F6Publishing: 12]  [Article Influence: 0.7]  [Reference Citation Analysis (0)]
22.  Aviram-Goldring A, Goldman B, Netanelov-Shapira I, Chen-Shtoyerman R, Zvulunov A, Tal O, Ilan T, Peleg L. Deletion patterns of the STS gene and flanking sequences in Israeli X-linked ichthyosis patients and carriers: analysis by polymerase chain reaction and fluorescence in situ hybridization techniques. Int J Dermatol. 2000;39:182-187.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 28]  [Cited by in F6Publishing: 30]  [Article Influence: 1.3]  [Reference Citation Analysis (0)]
23.  Ballabio A, Carrozzo R, Parenti G, Gil A, Zollo M, Persico MG, Gillard E, Affara N, Yates J, Ferguson-Smith MA. Molecular heterogeneity of steroid sulfatase deficiency: a multicenter study on 57 unrelated patients, at DNA and protein levels. Genomics. 1989;4:36-40.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 75]  [Cited by in F6Publishing: 83]  [Article Influence: 2.4]  [Reference Citation Analysis (0)]
24.  Shapiro LJ, Yen P, Pomerantz D, Martin E, Rolewic L, Mohandas T. Molecular studies of deletions at the human steroid sulfatase locus. Proc Natl Acad Sci USA. 1989;86:8477-8481.  [PubMed]  [DOI]  [Cited in This Article: ]
25.  Nomura K, Nakano H, Umeki K, Harada K, Kon A, Tamai K, Sawamura D, Hashimoto I. A study of the steroid sulfatase gene in families with X-linked ichthyosis using polymerase chain reaction. Acta Derm Venereol. 1995;75:340-342.  [PubMed]  [DOI]  [Cited in This Article: ]
26.  Valdes-Flores M, Kofman-Alfaro SH, Vaca AL, Cuevas-Covarrubias SA. Mutation report: a novel partial deletion of exons 2-10 of the STS gene in recessive X-linked ichthyosis. J Invest Dermatol. 2000;114:591-593.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 18]  [Cited by in F6Publishing: 19]  [Article Influence: 0.8]  [Reference Citation Analysis (0)]
27.  Valdes-Flores M, Kofman-Alfaro SH, Vaca AL, Cuevas-Covarrubias SA. Deletion of exons 1-5 of the STS gene causing X-linked ichthyosis. J Invest Dermatol. 2001;116:456-458.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 15]  [Cited by in F6Publishing: 17]  [Article Influence: 0.8]  [Reference Citation Analysis (0)]
28.  Valdes-Flores M, Vaca AL, Rivera-Vega MR, Kofman-Alfaro SH, Cuevas-Covarrubias SA. Maternal transmission of the 3 bp deletion within exon 7 of the STS gene in steroid sulfatase deficiency. J Invest Dermatol. 2001;117:997-999.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 4]  [Cited by in F6Publishing: 5]  [Article Influence: 0.2]  [Reference Citation Analysis (0)]
29.  Winge MC, Hoppe T, Liedén A, Nordenskjöld M, Vahlquist A, Wahlgren CF, Törmä H, Bradley M, Berne B. Novel point mutation in the STS gene in a patient with X-linked recessive ichthyosis. J Dermatol Sci. 2011;63:62-64.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 11]  [Cited by in F6Publishing: 12]  [Article Influence: 1.0]  [Reference Citation Analysis (0)]
30.  Liao H, Waters AJ, Goudie DR, Aitken DA, Graham G, Smith FJ, Lewis-Jones S, McLean WH. Filaggrin mutations are genetic modifying factors exacerbating X-linked ichthyosis. J Invest Dermatol. 2007;127:2795-2798.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 45]  [Cited by in F6Publishing: 46]  [Article Influence: 2.9]  [Reference Citation Analysis (0)]
31.  Basler E, Grompe M, Parenti G, Yates J, Ballabio A. Identification of point mutations in the steroid sulfatase gene of three patients with X-linked ichthyosis. Am J Hum Genet. 1992;50:483-491.  [PubMed]  [DOI]  [Cited in This Article: ]
32.  Morita E, Katoh O, Shinoda S, Hiragun T, Tanaka T, Kameyoshi Y, Yamamoto S. A novel point mutation in the steroid sulfatase gene in X-linked ichthyosis. J Invest Dermatol. 1997;109:244-245.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 19]  [Cited by in F6Publishing: 20]  [Article Influence: 0.8]  [Reference Citation Analysis (0)]
33.  Alperin ES, Shapiro LJ. Characterization of point mutations in patients with X-linked ichthyosis. Effects on the structure and function of the steroid sulfatase protein. J Biol Chem. 1997;272:20756-20763.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 54]  [Cited by in F6Publishing: 54]  [Article Influence: 2.1]  [Reference Citation Analysis (0)]
34.  Gonzalez-Huerta LM, Messina-Baas OM, Toral-Lopez J, Rivera-Vega MR, Kofman-Alfaro S, Cuevas-Covarrubias SA. Point mutation in the STS gene in a severely affected patient with X-linked recessive ichthyosis. Acta Derm Venereol. 2006;86:78-79.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in F6Publishing: 2]  [Reference Citation Analysis (0)]
35.  Oyama N, Satoh M, Iwatsuki K, Kaneko F. Novel point mutations in the steroid sulfatase gene in patients with X-linked ichthyosis: transfection analysis using the mutated genes. J Invest Dermatol. 2000;114:1195-1199.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 17]  [Cited by in F6Publishing: 18]  [Article Influence: 0.8]  [Reference Citation Analysis (0)]
36.  Valdes-Flores M, Jimenez Vaca AL, Kofman-Alfaro SH, Cuevas-Covarrubias SA. Characterization of a novel point mutation (Arg432His) in X-linked ichthyosis. Acta Derm Venereol. 2001;81:54-55.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in F6Publishing: 1]  [Reference Citation Analysis (0)]
37.  González-Huerta LM, Riviera-Vega MR, Kofman-Alfeuro SH, Cuevas-Covarrubias SA. Novel missense mutation (Arg432Cys) in a patient with steroid sulphatase-deficiency. Clin Endocrinol (Oxf). 2003;59:263-264.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 4]  [Cited by in F6Publishing: 6]  [Article Influence: 0.3]  [Reference Citation Analysis (0)]
38.  Sugawara T, Shimizu H, Hoshi N, Fujimoto Y, Nakajima A, Fujimoto S. PCR diagnosis of X-linked ichthyosis: identification of a novel mutation (E560P) of the steroid sulfatase gene. Hum Mutat. 2000;15:296.  [PubMed]  [DOI]  [Cited in This Article: ]
39.  Nishimura S, Masuda H, Matsumoto T, Sakura N, Matsumoto T, Ueda K. Two cases of steroid sulfatase deficiency with complex phenotype due to contiguous gene deletions. Am J Med Genet. 1991;40:260-263.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 18]  [Cited by in F6Publishing: 19]  [Article Influence: 0.6]  [Reference Citation Analysis (0)]
40.  Gillard EF, Affara NA, Yates JR, Goudie DR, Lambert J, Aitken DA, Ferguson-Smith MA. Deletion of a DNA sequence in eight of nine families with X-linked ichthyosis (steroid sulphatase deficiency). Nucleic Acids Res. 1987;15:3977-3985.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 49]  [Cited by in F6Publishing: 66]  [Article Influence: 1.8]  [Reference Citation Analysis (0)]
41.  Ballabio A, Bardoni B, Guioli S, Basler E, Camerino G. Two families of low-copy-number repeats are interspersed on Xp22.3: implications for the high frequency of deletions in this region. Genomics. 1990;8:263-270.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 47]  [Cited by in F6Publishing: 51]  [Article Influence: 1.5]  [Reference Citation Analysis (0)]
42.  Yen PH, Li XM, Tsai SP, Johnson C, Mohandas T, Shapiro LJ. Frequent deletions of the human X chromosome distal short arm result from recombination between low copy repetitive elements. Cell. 1990;61:603-610.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 111]  [Cited by in F6Publishing: 122]  [Article Influence: 3.7]  [Reference Citation Analysis (0)]
43.  Li XM, Yen PH, Shapiro LJ. Characterization of a low copy repetitive element S232 involved in the generation of frequent deletions of the distal short arm of the human X chromosome. Nucleic Acids Res. 1992;20:1117-1122.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 38]  [Cited by in F6Publishing: 38]  [Article Influence: 1.2]  [Reference Citation Analysis (0)]
44.  Toral-Lopez J, González-Huerta LM, Cuevas-Covarrubias SA. Segregation analysis in X-linked ichthyosis: paternal transmission of the affected X-chromosome. Br J Dermatol. 2008;158:818-820.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 12]  [Cited by in F6Publishing: 13]  [Article Influence: 0.9]  [Reference Citation Analysis (0)]
45.  Saeki H, Kuwata S, Nakagawa H, Shimada S, Tamaki K, Ishibashi Y. Deletion pattern of the steroid sulphatase gene in Japanese patients with X-linked ichthyosis. Br J Dermatol. 1998;139:96-98.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 14]  [Cited by in F6Publishing: 14]  [Article Influence: 0.6]  [Reference Citation Analysis (0)]
46.  Jimenez Vaca AL, Valdes-Flores Mdel R, Rivera-Vega MR, González-Huerta LM, Kofman-Alfaro SH, Cuevas-Covarrubias SA. Deletion pattern of the STS gene in X-linked ichthyosis in a Mexican population. Mol Med. 2001;7:845-849.  [PubMed]  [DOI]  [Cited in This Article: ]
47.  Bradshaw KD, Carr BR. Placental sulfatase deficiency: maternal and fetal expression of steroid sulfatase deficiency and X-linked ichthyosis. Obstet Gynecol Surv. 1986;41:401-413.  [PubMed]  [DOI]  [Cited in This Article: ]
48.  Hazan C, Orlow SJ, Schaffer JV. X-linked recessive ichthyosis. Dermatol Online J. 2005;11:12.  [PubMed]  [DOI]  [Cited in This Article: ]
49.  Høyer H, Lykkesfeldt G, Ibsen HH, Brandrup F. Ichthyosis of steroid sulphatase deficiency. Clinical study of 76 cases. Dermatologica. 1986;172:184-190.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 18]  [Cited by in F6Publishing: 19]  [Article Influence: 0.5]  [Reference Citation Analysis (0)]
50.  Wells RS, Jennings MC. X-linked ichthyosis and ichthyosis vulgaris. Clinical and genetic distinctions in a second series of families. JAMA. 1967;202:485-488.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 12]  [Cited by in F6Publishing: 16]  [Article Influence: 0.3]  [Reference Citation Analysis (0)]
51.  Shapiro LJ. X-linked ichthyosis. Int J Dermatol. 1981;20:26-31.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 11]  [Cited by in F6Publishing: 12]  [Article Influence: 0.3]  [Reference Citation Analysis (0)]
52.  Elias PM, Williams ML, Choi EH, Feingold KR. Role of cholesterol sulfate in epidermal structure and function: lessons from X-linked ichthyosis. Biochim Biophys Acta. 2014;1841:353-361.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 72]  [Cited by in F6Publishing: 63]  [Article Influence: 6.3]  [Reference Citation Analysis (0)]
53.  Okano M, Kitano Y, Yoshikawa K, Nakamura T, Matsuzawa Y, Yuasa T. X-linked ichthyosis and ichthyosis vulgaris: comparison of their clinical features based on biochemical analysis. Br J Dermatol. 1988;119:777-783.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 23]  [Cited by in F6Publishing: 25]  [Article Influence: 0.7]  [Reference Citation Analysis (0)]
54.  Mevorah B, Krayenbuhl A, Bovey EH, van Melle GD. Autosomal dominant ichthyosis and X-linked ichthyosis. Comparison of their clinical and histological phenotypes. Acta Derm Venereol. 1991;71:431-434.  [PubMed]  [DOI]  [Cited in This Article: ]
55.  Delfino M, De Ritis G, Fabbrocini G, Procaccini EM, Illiano GM, Piccirillo A. [Sweat-gland function in patients with X-linked ichthyosis]. Recenti Prog Med. 1991;82:677-678.  [PubMed]  [DOI]  [Cited in This Article: ]
56.  Gruber R, Janecke AR, Grabher D, Sandilands A, Fauth C, Schmuth M. Evidence for genetic modifiers other than filaggrin mutations in X-linked ichthyosis. J Dermatol Sci. 2010;58:72-75.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 7]  [Cited by in F6Publishing: 7]  [Article Influence: 0.5]  [Reference Citation Analysis (0)]
57.  Ramesh R, Chen H, Kukula A, Wakeling EL, Rustin MH, McLean WH. Exacerbation of X-linked ichthyosis phenotype in a female by inheritance of filaggrin and steroid sulfatase mutations. J Dermatol Sci. 2011;64:159-162.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 15]  [Cited by in F6Publishing: 12]  [Article Influence: 1.0]  [Reference Citation Analysis (0)]
58.  Costagliola C, Fabbrocini G, Illiano GM, Scibelli G, Delfino M. Ocular findings in X-linked ichthyosis: a survey on 38 cases. Ophthalmologica. 1991;202:152-155.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 29]  [Cited by in F6Publishing: 31]  [Article Influence: 1.0]  [Reference Citation Analysis (0)]
59.  Haritoglou C, Ugele B, Kenyon KR, Kampik A. Corneal manifestations of X-linked ichthyosis in two brothers. Cornea. 2000;19:861-863.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 16]  [Cited by in F6Publishing: 17]  [Article Influence: 0.7]  [Reference Citation Analysis (0)]
60.  Jay B, Blach RK, Wells RS. Ocular manifestations of ichthyosis. Br J Ophthalmol. 1968;52:217-226.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 65]  [Cited by in F6Publishing: 69]  [Article Influence: 1.3]  [Reference Citation Analysis (0)]
61.  Piccirillo A, Auricchio L, Fabbrocini G, Parenti G, Ballabio A, Delfino M. Ocular findings and skin histology in a group of patients with X-linked ichthyosis. Br J Dermatol. 1988;119:185-188.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 16]  [Cited by in F6Publishing: 17]  [Article Influence: 0.5]  [Reference Citation Analysis (0)]
62.  Sever RJ, Frost P, Weinstein G. Eye changes in ichthyosis. JAMA. 1968;206:2283-2286.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 53]  [Cited by in F6Publishing: 53]  [Article Influence: 1.0]  [Reference Citation Analysis (0)]
63.  Steuhl KP, Anton-Lamprecht I, Arnold ML, Thiel HJ. Recurrent bilateral corneal erosions due to an association of epidermolysis bullosa simplex Köbner and X-linked ichthyosis with steroid sulfatase deficiency. Graefes Arch Clin Exp Ophthalmol. 1988;226:216-223.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 12]  [Cited by in F6Publishing: 13]  [Article Influence: 0.4]  [Reference Citation Analysis (0)]
64.  Traupe H, Happle R. Mechanisms in the association of cryptorchidism and X-linked recessive ichthyosis. Dermatologica. 1986;172:327-328.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 17]  [Cited by in F6Publishing: 18]  [Article Influence: 0.5]  [Reference Citation Analysis (0)]
65.  Lykkesfeldt G, Høyer H, Lykkesfeldt AE, Skakkebaek NE. Steroid sulphatase deficiency associated with testis cancer. Lancet. 1983;2:1456.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 33]  [Cited by in F6Publishing: 37]  [Article Influence: 0.9]  [Reference Citation Analysis (0)]
66.  Ozawa H, Osawa M, Nagai T, Sakura N. Steroid sulfatase deficiency with bilateral periventricular nodular heterotopia. Pediatr Neurol. 2006;34:239-241.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 9]  [Cited by in F6Publishing: 11]  [Article Influence: 0.6]  [Reference Citation Analysis (0)]
67.  Kent L, Emerton J, Bhadravathi V, Weisblatt E, Pasco G, Willatt LR, McMahon R, Yates JR. X-linked ichthyosis (steroid sulfatase deficiency) is associated with increased risk of attention deficit hyperactivity disorder, autism and social communication deficits. J Med Genet. 2008;45:519-524.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 111]  [Cited by in F6Publishing: 118]  [Article Influence: 7.9]  [Reference Citation Analysis (0)]
68.  Bicikova M, Hill M, Ripova D, Mohr P, Hampl R. Determination of steroid metabolome as a possible tool for laboratory diagnosis of schizophrenia. J Steroid Biochem Mol Biol. 2013;133:77-83.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 43]  [Cited by in F6Publishing: 42]  [Article Influence: 4.2]  [Reference Citation Analysis (0)]
69.  Garcıa-Bravo B, Unamuno P. Ictiosis X. Monogr Dermatol. 1991;1:27-37.  [PubMed]  [DOI]  [Cited in This Article: ]
70.  De Unamuno P, Martin-Pascual A, Garcia-Perez A. X-linked ichthyosis. Br J Dermatol. 1977;97:53-58.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 16]  [Cited by in F6Publishing: 17]  [Article Influence: 0.4]  [Reference Citation Analysis (0)]
71.  Garcia Perez A, Crespo M. X-linked ichthyosis associated with hypertrophic pyloric stenosis in three brothers. Clin Exp Dermatol. 1981;6:159-161.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 9]  [Cited by in F6Publishing: 10]  [Article Influence: 0.2]  [Reference Citation Analysis (0)]
72.  Stoll C, Grosshans E, Binder P, Roth MP. Hypertrophic pyloric stenosis associated with X-linked ichthyosis in two brothers. Clin Exp Dermatol. 1983;8:61-64.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 5]  [Cited by in F6Publishing: 6]  [Article Influence: 0.2]  [Reference Citation Analysis (0)]
73.  Mallory SB, Kletzel M, Turley CP. X-linked ichthyosis with acute lymphoblastic leukemia. Arch Dermatol. 1988;124:22-24.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 7]  [Cited by in F6Publishing: 8]  [Article Influence: 0.2]  [Reference Citation Analysis (0)]
74.  Matsukura H, Fuchizawa T, Ohtsuki A, Higashiyama H, Higuchi O, Higuchi A, Miyawaki T. End-stage renal failure in a child with X-linked ichthyosis. Pediatr Nephrol. 2003;18:297-300.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 7]  [Cited by in F6Publishing: 8]  [Article Influence: 0.4]  [Reference Citation Analysis (0)]
75.  Mishra K, Batra VV, Basu S, Rath B, Saxena R. Steroid-resistant nephrotic syndrome associated with steroid sulfatase deficiency-x-linked recessive ichthyosis: a case report and review of literature. Eur J Pediatr. 2012;171:847-850.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 7]  [Cited by in F6Publishing: 8]  [Article Influence: 0.7]  [Reference Citation Analysis (0)]
76.  Long SA, Wertz PW, Strauss JS, Downing DT. Human stratum corneum polar lipids and desquamation. Arch Dermatol Res. 1985;277:284-287.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 151]  [Cited by in F6Publishing: 151]  [Article Influence: 4.0]  [Reference Citation Analysis (0)]
77.  Rearick JI, Albro PW, Jetten AM. Increase in cholesterol sulfotransferase activity during in vitro squamous differentiation of rabbit tracheal epithelial cells and its inhibition by retinoic acid. J Biol Chem. 1987;262:13069-13074.  [PubMed]  [DOI]  [Cited in This Article: ]
78.  Shimada M, Matsuda T, Sato A, Akase T, Matsubara T, Nagata K, Yamazoe Y. Expression of a skin cholesterol sulfotransferase, St2b2, is a trigger of epidermal cell differentiation. Xenobiotica. 2008;38:1487-1499.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 8]  [Cited by in F6Publishing: 7]  [Article Influence: 0.5]  [Reference Citation Analysis (0)]
79.  Hanyu O, Nakae H, Miida T, Higashi Y, Fuda H, Endo M, Kohjitani A, Sone H, Strott CA. Cholesterol sulfate induces expression of the skin barrier protein filaggrin in normal human epidermal keratinocytes through induction of RORα. Biochem Biophys Res Commun. 2012;428:99-104.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 24]  [Cited by in F6Publishing: 22]  [Article Influence: 2.0]  [Reference Citation Analysis (0)]
80.  Elias PM, Williams ML, Feingold KR. Abnormal barrier function in the pathogenesis of ichthyosis: therapeutic implications for lipid metabolic disorders. Clin Dermatol. 2012;30:311-322.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 40]  [Cited by in F6Publishing: 44]  [Article Influence: 4.0]  [Reference Citation Analysis (0)]
81.  Mesquita-Guimarães J. X-linked ichthyosis. Ultrastructural study of 4 cases. Dermatologica. 1981;162:157-166.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 19]  [Cited by in F6Publishing: 20]  [Article Influence: 0.5]  [Reference Citation Analysis (0)]
82.  Kashork CD, Sutton VR, Fonda Allen JS, Schmidt DE, Likhite ML, Potocki L, O’Brien WE, Shaffer LG. Low or absent unconjugated estriol in pregnancy: an indicator for steroid sulfatase deficiency detectable by fluorescence in situ hybridization and biochemical analysis. Prenat Diagn. 2002;22:1028-1032.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 31]  [Cited by in F6Publishing: 33]  [Article Influence: 1.6]  [Reference Citation Analysis (0)]
83.  Marcos J, Craig WY, Palomaki GE, Kloza EM, Haddow JE, Roberson M, Bradley LA, Shackleton CH. Maternal urine and serum steroid measurements to identify steroid sulfatase deficiency (STSD) in second trimester pregnancies. Prenat Diagn. 2009;29:771-780.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 23]  [Cited by in F6Publishing: 24]  [Article Influence: 1.7]  [Reference Citation Analysis (0)]
84.  Craig WY, Palomaki G, Roberson M, Haddow JE. Further insights into implications of undetectable or very low unconjugated estriol in maternal serum during the second trimester. Prenat Diagn. 2011;31:616-618.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 7]  [Cited by in F6Publishing: 61]  [Article Influence: 5.1]  [Reference Citation Analysis (0)]
85.  Richard G. Molecular genetics of the ichthyoses. Am J Med Genet C Semin Med Genet. 2004;131C:32-44.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 46]  [Cited by in F6Publishing: 50]  [Article Influence: 2.8]  [Reference Citation Analysis (0)]
86.  Cuevas-Covarrubias SA, Kofman-Alfaro SH, Maya-Núñez G, Díaz-Zagoya JC, Orozco Orozco E. X-linked ichthyosis in Mexico: high frequency of deletions in the steroid sulfatase encoding gene. Am J Med Genet. 1997;72:415-416.  [PubMed]  [DOI]  [Cited in This Article: ]
87.  Oji V, Traupe H. Ichthyoses: differential diagnosis and molecular genetics. Eur J Dermatol. 2006;16:349-359.  [PubMed]  [DOI]  [Cited in This Article: ]
88.  Fleckman P, Newell BD, van Steensel MA, Yan AC. Topical treatment of ichthyoses. Dermatol Ther. 2013;26:16-25.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 11]  [Cited by in F6Publishing: 13]  [Article Influence: 1.3]  [Reference Citation Analysis (0)]
89.  Cotellessa C, Cuevas-Covarrubias SA, Valeri P, Fargnoli MC, Peris K. Topical tazarotene 0.05% versus glycolic acid 70% treatment in X-linked ichthyosis due to extensive deletion of the STS gene. Acta Derm Venereol. 2005;85:346-348.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in F6Publishing: 2]  [Reference Citation Analysis (0)]
90.  Kragballe K, Steijlen PM, Ibsen HH, van de Kerkhof PC, Esmann J, Sorensen LH, Axelsen MB. Efficacy, tolerability, and safety of calcipotriol ointment in disorders of keratinization. Results of a randomized, double-blind, vehicle-controlled, right/left comparative study. Arch Dermatol. 1995;131:556-560.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 68]  [Cited by in F6Publishing: 70]  [Article Influence: 2.5]  [Reference Citation Analysis (0)]
91.  Lucker GP, Verfaille CJ, Heremans AM, Vanhoutte FP, Boegheim JP, Steijlen PP. Topical liarozole in ichthyosis: a double-blind, left-right comparative study followed by a long-term open maintenance study. Br J Dermatol. 2005;152:566-569.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 25]  [Cited by in F6Publishing: 27]  [Article Influence: 1.5]  [Reference Citation Analysis (0)]
92.  Verfaille CJ, Vanhoutte FP, Blanchet-Bardon C, van Steensel MA, Steijlen PM. Oral liarozole vs. acitretin in the treatment of ichthyosis: a phase II/III multicentre, double-blind, randomized, active-controlled study. Br J Dermatol. 2007;156:965-973.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 48]  [Cited by in F6Publishing: 51]  [Article Influence: 3.2]  [Reference Citation Analysis (0)]
93.  Gånemo A, Virtanen M, Vahlquist A. Improved topical treatment of lamellar ichthyosis: a double-blind study of four different cream formulations. Br J Dermatol. 1999;141:1027-1032.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 61]  [Cited by in F6Publishing: 65]  [Article Influence: 2.7]  [Reference Citation Analysis (0)]
94.  Blanchet-Bardon C, Tadini G, Machado Matos M, Delarue A. Association of glycerol and paraffin in the treatment of ichthyosis in children: an international, multicentric, randomized, controlled, double-blind study. J Eur Acad Dermatol Venereol. 2012;26:1014-1019.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 21]  [Cited by in F6Publishing: 23]  [Article Influence: 1.9]  [Reference Citation Analysis (0)]
95.  Hernández-Martin A, Aranegui B, Martin-Santiago A, Garcia-Doval I. A systematic review of clinical trials of treatments for the congenital ichthyoses, excluding ichthyosis vulgaris. J Am Acad Dermatol. 2013;69:544-549.e8.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 32]  [Cited by in F6Publishing: 36]  [Article Influence: 3.6]  [Reference Citation Analysis (0)]